Prothena | PRTA - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Acadia Pharmaceuticals USD 148.57M 12.22M 2026-06
Agios Pharmaceuticals USD 38.46M 4.51M 2026-03
Akebia Therapeutics USD 23.53M 3.19M 2025-12
ALKERMES USD 196.64M 67.96M 2026-06
Alnylam Pharmaceuticals USD 342M 5.92M 2026-09
Amgen USD 1.72B 134M 2026-06
Biogen USD 752M 42.3M 2026-09
BioMarin Pharmaceutical USD 333.64M 61.91M 2026-09
Exelixis USD 154.56M 6.93M 2026-09
Immunic USD 3.45M 451K 2025-12
Incyte USD 364.27M 12.54M 2026-09
Ionis Pharmaceuticals USD 130.07M 20.92M 2026-06
MacroGenics USD 7.9M 1.81M 2026-06
Nektar Therapeutics USD 11.87M 1.7M 2026-03
Neurocrine Biosciences USD 366.3M 16.8M 2026-09
Prothena USD 10.9M 1.77M 2026-06
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Ultragenyx Pharmaceutical USD 88M 0 2026-06
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09